Fig. 6
The simultaneous PROK1 expression in plasma and primary cancer lesion was associated with a lower CRS even among people who received adjuvant chemotherapy. A In all stages, the PROK1-positive group showed a lower CRS than that of the negative group. B Among stage III patients, the PROK1-positive group was clearly associated with a lower CRS